Bristol Myers Squibb Co.: NYSE:BMY market news - Google Finance

Search Images Maps Play YouTube News Gmail Drive More »

Recent Quotes (30 days)

You have no recent quotes

chg | %

Bristol Myers Squibb Co. news

Watch this stock

Showing stories 1 - 9 of about 9

Articles published

All dates (95)
2013
May (1)
April (2)
March (2)
February (2)

BMY 46.52 +0.12 (0.26%)

price chart

Medivir AB Announces Interferon-Free Phase II Combination Trial with TMC435 and Daclatasvir in Collaboration with Janssen R&D Ireland and Bristol-Myers Squibb Co.

Reuters Key Development - Jun 29, 2012

Bristol-Myers Squibb Co Announces Dividend; Announces Authorization Of Additional $3 billion For Share Repurchase Program

Reuters Key Development - Jun 26, 2012

Bristol-Myers Squibb Co, Four Others Weigh Amylin Pharmaceuticals Inc Final Bids-Reuters

Reuters Key Development - Jun 26, 2012

Bristol-Myers Squibb Co And Pfizer, Inc. Receives Complete Response Letter From U.S. Food And Drug Administration For ELIQUIS (apixaban)

Reuters Key Development - Jun 25, 2012

Bristol-Myers Squibb Co And Emory University Announce Partnership To Advance Clinical Development Of Investigational Compounds

Reuters Key Development - Jun 20, 2012

Bristol-Myers Squibb Co and AstraZeneca PLC Announce New Data Show Investigational Compound Dapagliflozin Demonstrated Significant Reductions in Blood Sugar Levels When Added to Sitagliptin

Reuters Key Development - Jun 9, 2012

Bristol-Myers Squibb Co Announces Results Of AMPLE

Reuters Key Development - Jun 6, 2012

AstraZeneca PLC, Bristol-Myers Squibb Co Submits Initial Bids For Amylin Pharmaceuticals Inc-Reuters

Reuters Key Development - Jun 4, 2012

Bristol-Myers Squibb Co. Announces Interim Results From Expanded Phase 1 Dose-Ranging Study 003 (n=296) Of Investigational Anti-PD-1 Immunotherapy (BMS-936558)

Reuters Key Development - Jun 2, 2012